The US Food and Drug Administration’s impartial vaccine advisers are expected today to debate and vote on whether or not to advocate authorization of boosters for the Moderna Covid-19 vaccine.
On Friday, the advisers are scheduled to debate and vote on whether or not to advocate authorization of boosters for Johnson & Johnson’s Covid-19 vaccine. Both vaccines are already licensed to be used in individuals age 18 and older. Members of the Vaccines and Related Biological Products Advisory Committee can even hear a presentation on Friday on “mix and match” booster doses.
The committee of impartial advisers usually discusses and makes suggestions to the FDA round vaccine authorizations and approvals, and the company then makes the ultimate determination about whether or not to OK vaccines.